HLG NPAT jumped 74.8% off a weak base, but FCF sat below historical mean

Each of those growth rates is unprecedented against Annolyse's historical baseline (revenue mean 4.0%, PBT mean -1.3%, NPAT mean -1.5%), but the prior comparable was unusually soft: HY22 revenue fell 6.2% and NPAT fell 40.0% on COVID-related disruption.

Operating cash flow rose 64.8% to NZ$35.0m, and the interim dividend lifted to 24.0 cents per share from 18.0 cents. Two offsets sit beneath the headlines: gross margin contracted 140 bps to 56.5%, and capex rose 159.5% to NZ$7.9m (3.5% of revenue versus 1.8% a year earlier). Pre-lease free cash flow at NZ$27.1m is up NZ$8.9m year-on-year but sits at the lower edge of the historical range (mean NZ$32.1m).

• PBT margin of 13.2% and NPAT margin of 9.3% are both within the supplied historical range (means 12.6% and 8.9%), and gross margin actually fell 140 bps. The unprecedented growth rates therefore reflect a weak HY22 base rather than a structural step-up in earnings power, which matters because the read-through to FY23 is closer to a return to trend than a new earnings level.
• Working capital absorbed NZ$5.9m versus a historical mean of NZ$0.6m. Inventory grew 27.3% to NZ$28.5m, pushing inventory days to 23.2 — the upper edge of the historical range. With revenue growing 30.9% the inventory build is broadly proportionate, but the absolute cash absorption is above normal and is the main reason cash generation lagged earnings.
• Capex tripled while FCF stayed below its historical average. Capex of NZ$7.9m is up 159.5% and lifted capital intensity from 1.8% to 3.5% of revenue. With no commentary on what is being funded, the step-up is unexplained and matters for the durability of the elevated dividend (24 cps; payout 68.8% of NPAT).

The supplied second-half shape shows HY22 contributed only 48.6% of FY22 revenue and 46.5% of FY22 NPAT, indicating the business is typically second-half weighted; however, that pattern is distorted because HY22 was itself COVID-affected. Annualising current first-half revenue gives roughly NZ$446.6m, but applying the historical first-half share to this result would imply something higher, and neither anchor is reliable given the comparable's quality.

The release commentary describes the result as in line with prior guidance given in February. Beyond that, the release does not support a specific FY23 trajectory, so the second-half outcome remains the principal open variable.

On that basis the profit lift is real and durable in composition.

Cash quality is weaker than earnings quality. FCF-to-NPAT fell from 152.9% to 130.3%, and pre-lease FCF of NZ$27.1m is NZ$5.0m below the historical mean despite earnings being at a record. The drivers are identifiable rather than mysterious — a NZ$5.9m working-capital build (above normal range) and a NZ$4.8m year-on-year capex increase — but together they mean reported earnings overstate this period's cash generation relative to history. ROE of 22.3% (versus 13.7% prior) confirms the operating rebound, yet sits below the three-period mean of 26.8%.

This briefing cannot assess management's internal expectations for the second half or the medium-term capital plan, because neither forward targets nor capex guidance are disclosed in the release.